Bank of America raises Vertex Pharmaceuticals (NASDAQ:VRTX) price target from $350 to $400

By / / Bank of America, Vertex

Bank of America Securities analyst Ying Huang maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $350 to $400.

Scroll to Top